Switch to
More onapp

How to use scorecard? Learn more

Shukra Pharmaceuticals Ltd

SHUKRAPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹517 cr, stock is ranked 1,692
High RiskStock is 5.55x as volatile as Nifty
113.562.31 (-1.99%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

High

Strong financials and growth story over the years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹517 cr, stock is ranked 1,692
High RiskStock is 5.55x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
27.92
PB RatioPB Ratio
20.47
Dividend YieldDiv. Yield
0.04%
Sector PESector PE
42.90
Sector PBSector PB
6.03
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.

Financial TrendFinancial statements 

202020212022202311.9511.5620.5760.030.020.200.754.40
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnApr 24, 2024

Shukra Pharmaceuticals Ltd - 524632 - Certification Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024. | Download

Shukra Pharmaceuticals Ltd - 524632 - Certification Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024. | Download

Company Update 
Announced OnApr 11, 2024

Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

Cash Dividend 
Ex. DateSep 15, 2023

Final • Div/Share: ₹ 0.5

See all events